Daniel Doza

Daniel Doza

Company: Pfizer

Job title: Scientist


Investigating the Impact of Systemic & Targeted TGF-β Blockade on Fibrosis and Inflammation 3:30 pm

Comparing systemic TGF-β R1 inhibition to restricted targeting Uncovering the unique effects on inflammation observed in fibrotic models Highlighting lessons learned for fibrosis therapeutics and beyond New Data!Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.